82 related articles for article (PubMed ID: 20805144)
1. A national study of physician recommendations to initiate and discontinue growth hormone for short stature.
Silvers JB; Marinova D; Mercer MB; Connors A; Cuttler L
Pediatrics; 2010 Sep; 126(3):468-76. PubMed ID: 20805144
[TBL] [Abstract][Full Text] [Related]
2. Patient, physician, and consumer drivers: referrals for short stature and access to specialty drugs.
Cuttler L; Marinova D; Mercer MB; Connors A; Meehan R; Silvers JB
Med Care; 2009 Aug; 47(8):858-65. PubMed ID: 19543124
[TBL] [Abstract][Full Text] [Related]
3. Current prescribing practices and opinions about growth hormone therapy: results of a nationwide survey of paediatric endocrinologists.
Hardin DS; Woo J; Butsch R; Huett B
Clin Endocrinol (Oxf); 2007 Jan; 66(1):85-94. PubMed ID: 17201806
[TBL] [Abstract][Full Text] [Related]
4. Insurance coverage, physician recommendations, and access to emerging treatments: growth hormone therapy for childhood short stature.
Finkelstein BS; Silvers JB; Marrero U; Neuhauser D; Cuttler L
JAMA; 1998 Mar; 279(9):663-8. PubMed ID: 9496983
[TBL] [Abstract][Full Text] [Related]
5. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
Sneed RC; May WL; Stencel C
Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
[TBL] [Abstract][Full Text] [Related]
6. Short stature and growth hormone therapy. A national study of physician recommendation patterns.
Cuttler L; Silvers JB; Singh J; Marrero U; Finkelstein B; Tannin G; Neuhauser D
JAMA; 1996 Aug; 276(7):531-7. PubMed ID: 8709401
[TBL] [Abstract][Full Text] [Related]
7. Estimated cost-effectiveness of growth hormone therapy for idiopathic short stature.
Lee JM; Davis MM; Clark SJ; Hofer TP; Kemper AR
Arch Pediatr Adolesc Med; 2006 Mar; 160(3):263-9. PubMed ID: 16520445
[TBL] [Abstract][Full Text] [Related]
8. The boom that never was: results of a 10 year audit of paediatric growth hormone prescribing in Scotland.
Paterson WF; Donaldson MD; Greene SA; Kelnar CJ; Smail PJ
Health Bull (Edinb); 2000 Nov; 58(6):457-66. PubMed ID: 12813777
[TBL] [Abstract][Full Text] [Related]
9. Combined use of growth hormone and gonadotropin-releasing hormone analogues: the national cooperative growth study experience.
Kohn B; Julius JR; Blethen SL
Pediatrics; 1999 Oct; 104(4 Pt 2):1014-8. PubMed ID: 10506254
[TBL] [Abstract][Full Text] [Related]
10. Survey of growth hormone treatment practices by 251 pediatric endocrinologists.
Wyatt DT; Mark D; Slyper A
J Clin Endocrinol Metab; 1995 Nov; 80(11):3292-7. PubMed ID: 7593441
[TBL] [Abstract][Full Text] [Related]
11. Use of growth hormone in non-growth hormone deficient children.
Sood A; Menon PS
Natl Med J India; 1998; 11(5):222-5. PubMed ID: 10997170
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone: do we have a national perspective of indications for its use?
Al-Herbish AS; Al-Jurayyan NA; Abobakr AM; Al-Nuaim AA
Saudi Med J; 2000 Jun; 21(6):536-8. PubMed ID: 11500700
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone therapy in short stature.
Knudtzon J; Aarskog D
Pediatrician; 1987; 14(3):172-7. PubMed ID: 3331011
[TBL] [Abstract][Full Text] [Related]
14. Lack of correlation between growth hormone provocative test results and subsequent growth rates during growth hormone therapy.
Bell JJ; Dana K
Pediatrics; 1998 Aug; 102(2 Pt 3):518-20. PubMed ID: 9685456
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone use in pediatric growth hormone deficiency and other pediatric growth disorders.
Rosenfeld R; Allen DB; MacGillivray MH; Alter C; Saenger P; Anhalt H; Hintz R; Katz HP
Am J Manag Care; 2000 Sep; 6(15 Suppl):S805-16. PubMed ID: 11184422
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone in the treatment of children with short stature.
Pediatrics; 1983 Dec; 72(6):891-4. PubMed ID: 6646934
[TBL] [Abstract][Full Text] [Related]
17. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
Ranke MB; Lindberg A; Price DA; Darendeliler F; Albertsson-Wikland K; Wilton P; Reiter EO;
Horm Res; 2007; 68(2):53-62. PubMed ID: 17228181
[TBL] [Abstract][Full Text] [Related]
18. Physician decisions to discontinue long-term medications using a two-stage framework: the case of growth hormone therapy.
Cuttler L; Silvers JB; Singh J; Tsai AC; Radcliffe D
Med Care; 2005 Dec; 43(12):1185-93. PubMed ID: 16299429
[TBL] [Abstract][Full Text] [Related]
19. Growth response in prepubertal children with idiopathic growth hormone deficiency during the first two years of treatment with human growth hormone. Analysis of the Kabi Pharmacia International Growth Study.
Ranke MB; Guilbaud O
Acta Paediatr Scand Suppl; 1991; 379():109-15; discussion 116. PubMed ID: 1815451
[TBL] [Abstract][Full Text] [Related]
20. Is insulin-like growth factor-1 monitoring useful in assessing the response to growth hormone of growth hormone-deficient children?
Lanes R; Jakubowicz S
J Pediatr; 2002 Nov; 141(5):606-10. PubMed ID: 12410186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
